[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545377":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":20,"locations":25,"responsibleParty":64,"collaborators":67,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":20,"eligibilityCriteria":76,"healthyVolunteers":72,"sex":77,"minAge":78,"maxAge":20,"enrollmentInfo":79,"targetDuration":20,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":20,"overallStatus":28,"whyStopped":20,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"SleepWell24 Smart Application","EXPERIMENTAL","This group will consists of participates who will be on study for 8 weeks using the Sleepwell24 application. Once 20 people are enrolled on the 8 week cohort, a 6 month cohort will open up for 20 different participants.",[13],"Behavioral: SleepWell24 Application",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BEHAVIORAL","SleepWell24 Application","The SleepWell24 application will use connections with a Shelly smart plug and a Fitbit Charge 4 along with weekly questionnaires to monitor CPAP usage.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Timothy Morgenthaler, MD","PRINCIPAL_INVESTIGATOR",[26,48],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Mayo Clinic in Arizona","RECRUITING","Scottsdale","Arizona","85259","United States","US",{"type":35,"coordinates":36},"Point",[37,38],-111.89903,33.50921,{"lat":38,"lon":37},[41,46],{"name":42,"role":43,"phone":44,"phoneExt":20,"email":45},"Betty Monari","CONTACT","480-574-2641","Monari.Betty@mayo.edu",{"name":47,"role":24,"phone":20,"phoneExt":20,"email":20},"Umesh Goswami, MD",{"facility":49,"status":28,"city":50,"state":51,"zip":52,"country":32,"countryCode":33,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Mayo Clinic in Rochester","Rochester","Minnesota","55905",{"type":35,"coordinates":54},[55,56],-92.4699,44.02163,{"lat":56,"lon":55},[59,63],{"name":60,"role":43,"phone":61,"phoneExt":20,"email":62},"Rebecca K Ra","507-284-2122","ra.rebecca@mayo.edu",{"name":23,"role":24,"phone":20,"phoneExt":20,"email":20},{"type":24,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Timothy Morgenthaler","Principal Investigator",[68],{"name":69,"class":6},"Arizona State University","100545377","app-based-optimization-of-long-term-cpap-adherence-and-quality-of-life-100545377",false,"NCT06381115","App-Based Optimization of Long-Term CPAP Adherence and Quality of Life","An App-Based, Precision Medicine Approach to Optimize Long-Term CPAP Adherence and Quality of Life","Inclusion Criteria:\n\n* In both trials of Aim 2, twenty adults (≥18 years) per trial will be recruited who are newly diagnosed with OSA and speak English.\n* In both trials, we will purposely recruit samples balanced by biological sex and OSA severity (apnea hypopnea index: 5-14 vs. ≥ 15).\n* Inclusion Criteria are the same for both Aim 2 trials; Adult patients from MCCSM sites who:\n\n  * Are diagnosed with OSA based on clinical diagnostic testing via laboratory or home-based sleep study;\n  * Own and have the functional and cognitive ability to use an Apple (iOS9 or higher) or Android (4.2 or higher) smartphone with minimal to no assistance;\n  * Are prescribed continuous or auto-titrated CPAP;\n  * Agree to using a smartphone application and wearable wrist sensor; and\n  * Speak and read English.\n\nExclusion Criteria:\n\n* Unwilling to complete study measures and engage with SleepWell24;\n* Refuse to not use the Fitbit application during the study trial;\n* Have any conditions that would impede full participation (e.g., communication or cognitive impairments that limit ability to read and\u002For follow directions, other acute or severe health, cognitive, or psychological conditions);\n* Currently participating in other lifestyle programs (e.g. active, formal weight loss program or research study; smoking cessation program, etc.);\n* Decide to use a different PAP device than ResMed Airsense 10;\n* Prescribed high-dose benzodiazepines (equivalent to \\> 1 mg lorazapam\u002Fnight);\n* Daily opioid medication use at night;'\n* Unwilling to discontinue use of any current wearable sensor for the duration of the trial;\n* Previous documented history of treatment\u002Freferral for claustrophobia;\n* Previous CPAP use;\n* Currently engaging in shiftwork defined as night shift or rotating day and night shifts; and\n* Currently pregnant, trying to conceive, or breastfeeding.","ALL","18 Years",{"count":80,"type":81},40,"ESTIMATED","INTERVENTIONAL",[84],"NA","The purpose of this study is to optimize the time of CPAP usage to at least 6 hours a night for 6 nights per week for people who have OSA with the help of a smartphone application called SmartWell24. This application aims to target CPAP adherence.",[87],"Obstructive Sleep Apnea","2026-08-12",{"date":90,"type":91},"2026-08-14","ACTUAL",{"date":93,"type":91},"2025-06-01",{"date":95,"type":81},"2026-10",{"name":5,"class":6},2]